Ratings by BofA Securities (Craig Bijou)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/28/2026 | Teleflex | TFX | Upgrade | Buy (Neutral) |
122.07 (124.12) |
1.68% | Details | |
| 9/10/2026 | Cooper Companies | COO | Downgrade | Neutral (Buy) |
63.48 (56.91) |
-10.35% | Details | |
| 7/7/2026 | RxSight Inc. | RXST | Maintain | Underperform (N/A) |
|
Details | ||
| 5/22/2026 | Haemonetics | HAE | Upgrade | Buy (Neutral) |
61.94 (104.68) |
69% | Details | |
| 5/1/2026 | Merit Medical Systems, Inc. | MMSI | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2026 | Integer Holding | ITGR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2026 | Bausch & Lomb Corp. | BLCO | Maintain | Underperform (N/A) |
|
Details | ||
| 4/13/2026 | Teleflex | TFX | Upgrade | Neutral (Underperform) |
118.39 (122.07) |
3.11% | Details | |
| 11/7/2025 | Haemonetics | HAE | Upgrade | Neutral (Underperform) |
50.72 (61.94) |
22.12% | Details | |
| 10/24/2025 | Integer Holding | ITGR | Downgrade | Neutral (Buy) |
73.89 (126.45) |
71.13% | Details | |
| 8/4/2025 | Bausch & Lomb Corp. | BLCO | Maintain | Underperform (N/A) |
|
Details | ||
| 4/3/2025 | RxSight Inc. | RXST | Downgrade | Underperform (Buy) |
26.12 (4.68) |
-82.08% | Details | |
| 3/21/2025 | RxSight Inc. | RXST | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Teleflex | TFX | Downgrade | Underperform (Neutral) |
135.13 (118.39) |
-12.39% | Details | |
| 2/20/2025 | Bausch & Lomb Corp. | BLCO | Maintain | Underperform (N/A) |
|
Details | ||
| 2/7/2025 | Haemonetics | HAE | Downgrade | Underperform (Neutral) |
62.99 (50.72) |
-19.48% | Details | |
| 1/9/2025 | Globus Medical | GMED | Upgrade | Neutral (Underperform) |
83.45 (61.51) |
-26.29% | Details | |
| 12/12/2024 | Bausch & Lomb Corp. | BLCO | New Coverage | Underperform (N/A) |
18.16 (17.11) |
-5.78% | Details | |
| 11/6/2024 | Globus Medical | GMED | Maintain | Underperform (N/A) |
|
Details | ||
| 9/16/2024 | Merit Medical Systems, Inc. | MMSI | Maintain | Neutral (N/A) |
|
Details | ||
| 9/11/2024 | Haemonetics | HAE | New Coverage | Neutral (N/A) |
73.94 (104.68) |
41.57% | Details | |
| 8/5/2024 | Merit Medical Systems, Inc. | MMSI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/31/2024 | Cooper Companies | COO | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Integra LifeSciences | IART | Maintain | Underperform (N/A) |
|
Details | ||
| 4/15/2024 | Integer Holding | ITGR | Upgrade | Buy (Neutral) |
115.77 (73.89) |
-36.18% | Details | |
| 2/7/2024 | Merit Medical Systems, Inc. | MMSI | New Coverage | Neutral (N/A) |
78.62 (85.37) |
8.59% | Details | |
| 12/8/2023 | Cooper Companies | COO | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2023 | GE HealthCare | GEHC | Maintain | Neutral (N/A) |
|
Details | ||
| 10/30/2023 | Cooper Companies | COO | New Coverage | Buy (N/A) |
306.88 (63.48) |
-79.31% | Details | |
| 10/26/2023 | Integra LifeSciences | IART | Maintain | Underperform (N/A) |
|
Details | ||
| 9/12/2023 | Sight Sciences Inc. | SGHT | Downgrade | Underperform (Neutral) |
6.51 (8.53) |
31.03% | Details | |
| 7/31/2023 | GE HealthCare | GEHC | New Coverage | Neutral (N/A) |
77.87 (64.29) |
-17.44% | Details | |
| 7/28/2023 | Integer Holding | ITGR | Maintain | Neutral (N/A) |
|
Details | ||
| 7/3/2023 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | RxSight Inc. | RXST | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2023 | Integer Holding | ITGR | New Coverage | Neutral (N/A) |
76.85 (126.45) |
64.54% | Details | |
| 2/13/2023 | Globus Medical | GMED | Downgrade | Underperform (Buy) |
60.28 (83.45) |
38.44% | Details | |
| 5/31/2022 | Bausch & Lomb Corp. | BLCO | New Coverage | Buy (N/A) |
17.69 (18.16) |
2.66% | Details | |
| 5/9/2022 | Teleflex | TFX | New Coverage | Neutral (N/A) |
269.61 (124.12) |
-53.96% | Details | |
| 3/9/2022 | Paragon 28, Inc | FNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Integra LifeSciences | IART | Maintain | Underperform (N/A) |
|
Details | ||
| 12/13/2021 | Globus Medical | GMED | Upgrade | Buy (Underperform) |
67.95 (60.28) |
-11.29% | Details |
